Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

Headshot of Ann Latner, JD
Commentary
Patients Continue Seeking Ivermectin as COVID-19 Therapy, Pharmacy Associations Speak Out
04/14/2022
Ann Latner, JD, reiterates the concerns of multiple pharmacy associations and other health care stakeholders regarding patients’ continued queries about ivermectin therapy.
Ann Latner, JD, reiterates the concerns of multiple pharmacy associations and other health care stakeholders regarding patients’ continued queries about ivermectin therapy.
Ann Latner, JD, reiterates the...
04/14/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Calcium Channel Blocker With an Exciting New Indication
04/11/2022
Dr Munger reviews new data showing a calcium channel blocker delayed disease progression and lowered insulin requirements in patients with type 1 diabetes.
Dr Munger reviews new data showing a calcium channel blocker delayed disease progression and lowered insulin requirements in patients with type 1 diabetes.
Dr Munger reviews new data...
04/11/2022
Pharmacy Learning Network
Commentary
Identifying and Addressing Pharmacist Burnout
04/05/2022
"Every day, pharmacists all over the country dedicate themselves to delivering quality health care to their patients. To do so, it is important that pharmacists also take care of themselves and support their own health and well-being," writes...
"Every day, pharmacists all over the country dedicate themselves to delivering quality health care to their patients. To do so, it is important that pharmacists also take care of themselves and support their own health and well-being," writes...
"Every day, pharmacists all over...
04/05/2022
Pharmacy Learning Network

Advertisement

Headshot of Mark Munger, PharmD, University of Utah
Commentary
Empagliflozin Efficacious, Safe for Acute Heart Failure
03/30/2022
Dr Munger shares new findings on empagliflozin's efficacy in patients with acute heart failure and predicts how these data will impact clinical practice.
Dr Munger shares new findings on empagliflozin's efficacy in patients with acute heart failure and predicts how these data will impact clinical practice.
Dr Munger shares new findings on...
03/30/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Parents Sue CVS After Children Mistakenly Given COVID-19 Vaccine Instead of Flu Shot
03/22/2022
Ann Latner, JD, spotlights a recent lawsuit against CVS after the pharmacy mistakenly administered COVID-19 vaccines instead of flu vaccines to 2 children under 12 years of age.
Ann Latner, JD, spotlights a recent lawsuit against CVS after the pharmacy mistakenly administered COVID-19 vaccines instead of flu vaccines to 2 children under 12 years of age.
Ann Latner, JD, spotlights a...
03/22/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Community Pharmacy Practice Has Reached Critical Clinical Juncture
03/15/2022
Mark Munger, PharmD, FCCP, FACC, FHFSA, provides an overview of how community pharmacy practice has shifted during the pandemic to increasingly incorporate primary clinical care.
Mark Munger, PharmD, FCCP, FACC, FHFSA, provides an overview of how community pharmacy practice has shifted during the pandemic to increasingly incorporate primary clinical care.
Mark Munger, PharmD, FCCP, FACC,...
03/15/2022
Pharmacy Learning Network

Advertisement

Headshot of Mark Munger, PharmD, University of Utah
Commentary
The Launch of Mark Cuban’s Cost Plus Drug Company May Come With a Price for US Health Care
03/09/2022
Mark Munger, PharmD, FCCP, FACC, FHFSA, breaks down pharmacy concerns beyond medication dispensing that could persist or worsen with the arrival of Mark Cuban's Cost Plus Drug Company.
Mark Munger, PharmD, FCCP, FACC, FHFSA, breaks down pharmacy concerns beyond medication dispensing that could persist or worsen with the arrival of Mark Cuban's Cost Plus Drug Company.
Mark Munger, PharmD, FCCP, FACC,...
03/09/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Mississippi Compounding Pharmacist Sentenced to 5 Years in Prison for Health Care Fraud
03/07/2022
Ann Latner, JD, shares a case in which a pharmacist and 2 coconspirators pleaded guilty after billing health plans over $515 million in fraudulent prescriptions.
Ann Latner, JD, shares a case in which a pharmacist and 2 coconspirators pleaded guilty after billing health plans over $515 million in fraudulent prescriptions.
Ann Latner, JD, shares a case in...
03/07/2022
Pharmacy Learning Network
Commentary
Early Recognition, Clinical Intervention Key to Improving Outcomes for Pediatric Type 2 Diabetes, Obesity, and PCOS
03/03/2022
Yvette C Terrie, BS Pharm, RPh, highlights the prevalence of comorbidities associated with type 2 diabetes and polycystic ovarian syndrome among pediatric patients, emphasizing how providers can help improve outcomes.
Yvette C Terrie, BS Pharm, RPh, highlights the prevalence of comorbidities associated with type 2 diabetes and polycystic ovarian syndrome among pediatric patients, emphasizing how providers can help improve outcomes.
Yvette C Terrie, BS Pharm, RPh,...
03/03/2022
Pharmacy Learning Network

Advertisement

Headshot of Mark Munger, PharmD, University of Utah
Commentary
Counseling for Alcohol Use in Patients With Cardiovascular Disease
02/28/2022
Mark Munger, PharmD, FCCP, FACC, FHFSA, highlights a recent World Health Federation report and advises pharmacists to counsel patients about alcohol use to reduce the risk of cardiovascular and respiratory problems.
Mark Munger, PharmD, FCCP, FACC, FHFSA, highlights a recent World Health Federation report and advises pharmacists to counsel patients about alcohol use to reduce the risk of cardiovascular and respiratory problems.
Mark Munger, PharmD, FCCP, FACC,...
02/28/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use